...
首页> 外文期刊>Heart >Comments on: 'The infective endocarditis team: recommendations from an international working group'
【24h】

Comments on: 'The infective endocarditis team: recommendations from an international working group'

机译:评论:“传染性心内膜炎小组:国际工作组的建议”

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor, Chambers et al give some wise recommendations regarding infective endocarditis management. They recognise the grim prognosis of the disease (mortality: 20-64%), the importance of dedicated teams of experts, and the prominent role of early surgery; despite this, they suggest that some patients can be adequately managed in centres without dedicated teams of experts and surgical facilities, and propose nine indications for transfer of patients to a surgical centre. In our opinion, every patient with infective endocarditis should be evaluated and treated in centres with dedicated experts and surgical facilities for several reasons: (1) severe complications may appear at any time and may require urgent diagnosis and treatment by experts; moreover, transferring a patient with septic shock or acute pulmonary oedema contributes to more clinical and haemodynamic instability; (2) an abscess, one of the indications proposed for transferring, and other peri-annular complications, may be missed by non-experts in imaging; (3) failure to respond to antibiotics is defined in the guidelines as the persistence of positive blood cultures 7-10 days after the initiation of antibiotic therapy, but this arbitrary cut-off point may be too late; (4) emboli can be silent or with subtle symptoms, and can be easily missed even by experts; (5) severe regurgitation in the context of a valve with important tissue damage can be difficult to assess. Our experience is in agreement with this concept. We used to recommend that patients could stay at their hospital if no high-risk markers were present; eventually, some of those patients were transferred to our centre with poorer clinical condition. Infective endocarditis is the cardiac disease with the highest rate of death, much higher than acute myocardial infarction and many types of cancers, which needs a combined medico-surgical therapeutic approach, which should be undertaken at medico-surgical centres.
机译:钱伯斯等人给编辑,关于感染性心内膜炎治疗的一些明智建议。他们认识到该病预后严峻(死亡率:20-64%),敬业的专家团队的重要性以及早期手术的突出作用。尽管如此,他们建议,即使没有专门的专家团队和手术设施,也可以在中心对一些患者进行适当的管理,并提出了将患者转移到手术中心的九种适应症。我们认为,每位感染性心内膜炎患者应在具有专职专家和手术设施的中心进行评估和治疗,原因如下:(1)随时可能出现严重的并发症,可能需要专家紧急诊断和治疗;此外,转移感染性休克或急性肺水肿的患者会导致更多的临床和血液动力学不稳定。 (2)非专家影像学专家可能会遗漏脓肿,建议的转移指征之一以及其他环周并发症。 (3)指南中对抗生素无效的定义是在开始抗生素治疗后7-10天持续出现阳性血液培养,但是这个任意的临界点可能为时已晚; (4)栓子可以是沉默的或带有微妙的症状,甚至容易被专家遗漏; (5)在瓣膜严重组织损伤的情况下严重的反流可能难以评估。我们的经验与这个概念一致。我们曾经建议,如果没有高危标志物,患者可以留在医院;最终,其中一些患者因临床状况较差而被转移到我们中心。感染性心内膜炎是死亡率最高的心脏病,远高于急性心肌梗塞和许多类型的癌症,这需要一种综合的外科手术治疗方法,应在外科手术中心进行。

著录项

  • 来源
    《Heart》 |2014年第16期|1301-1302|共2页
  • 作者单位

    Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clinico Universitario, Valladolid ES47005, Spain;

    Cardiology Department, Hospital Clinico San Carlos, Madrid, Spain;

    Department of Cardiology, Institute of Heart Sciences (ICICOR), Hospital Clinico Universitario, Valladolid, Spain;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号